Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters

Heart Disease Clinical Trials

A listing of Heart Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (24) clinical trials

Cerebrovascular Outcomes in Ischemic Heart Disease

This is a randomized control trial, with randomization nested within rationally-formed groups. Three major groups will be assessed: 1) Coronary artery disease (CAD) patients, 2) Metabolic Syndrome (MetS), and 3) healthy Control (CTL) participants. Allocation into the Healthy CTL versus MeTS groups will be confirmed at the pre-study screening visit ...

Phase N/A

Prospective Evaluation of Drug-Eluting Stents in Routine Clinical Practice (ASAN PCI Registry)

The objective of this study is to evaluate effectiveness and safety of drug-eluting stent implantation in the "real world" daily practice.

Phase N/A

Epicardial Fat in Cardiovascular Diseases

Epicardial adipose tissue (EAT) is the visceral fat depot of the heart. EAT transcriptome is unique when compared to subcutaneous fat. EAT is a highly inflammatory tissue enriched with genes involved in inflammation, endothelial function, immune signaling and thermoregulation. EAT has been correlated with coronary artery disease (CAD) and atrial ...

Phase N/A

Rehabilitation of Adolescents and Young Adults With Congenital Heart Diseases

Adolescents and adults with congenital heart disease (CHD) have reduced exercise capacity compared to the general population, even for "simple" heart disease. Regular physical activity is known to reduce the risk of acquired heart disease. Cardiac rehabilitation programs have been largely developed to manage adult coronary and heart failure patients, ...

Phase N/A

Cardiac Surgery Peer Support Recovery

Patients admitted with active IE secondary to IV drug use require a myriad of services and will remain hospitalized for a minimum of six weeks. During their hospitalization, infectious disease service assists in developing a treatment plan for the active infection, neurosurgery service evaluates and develops a plan to treat ...

Phase N/A

Health-economic Impact of Pulse Oximetry Systematic Screening of Critical Congenital Heart Disease in Asymptomatic Newborns

Persistant hypoxemia in the newborn confers, even isolated, an abnormal clinical situation, that needs to be addressed for an adequate diagnosis and an optimal treatment. If during the first hours of life, hypoxemia is frequent and often transient, beyond that, it is necessary to search the various etiological conditions such ...

Phase N/A

Anti-platelet Effect of Berberine in Patients After Elective Percutaneous Coronary Intervention

Background Dual antiplatelet therapy (DAPT) with aspirin and a platelet P2Y12 inhibitor is mandatory in patients after percutaneous coronary intervention (PCI). For patients with stable coronary artery disease (SCAD) and unstable angina (UA), clopidogrel is the most widely used P2Y12 inhibitor with class I recommendation. However, clopidogrel is a pro-drug ...

Phase

Flublok v. Standard Dose Vaccine Effectiveness Among Kaiser Permanente Northern California Adults 18-64 Years

The overall objective of this study is to describe the effectiveness of Flublok Quadrivalent vaccine compared to standard dose inactivated influenza vaccine (SD-IIV) in adults 18 through 64 years of age. During this study, Flublok Quadrivalent or SD-IIV will be administered according to the guidelines in the Prescribing Information materials ...

Phase N/A

Post-resuscitation Care Registry for Survival From Out-of-hospital Cardiac Arrest

This registry prospectively enrolls adults patients survived out-of-hospital cardiac arrest in 3 academic hospital emergency departments. Registered data can be used for quality control and clinical research to reduce post-cardiac arrest syndrome-related mortality.

Phase N/A

Reducing Lung CongestIon Symptoms in Advanced Heart Failure

This is a prospective, multi-center, 1:1 randomized, patient and observer blinded clinical study, with a Shunt Treatment arm and a non-implant Control arm. A total of approximately 400 patients will be randomized. Patients will be blinded during follow-up for a minimum of 12 months to a maximum of 24 months. ...

Phase N/A